69 Best Drug Development Startups to Watch in 2025

The Definitive Seedtable Ranking of Drug Development Startups

We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.

There are 85 start-ups with an aggregate funding of $5.2b. The average funding per company in this subset is $75.5m.

Last update to the database: Feb 18, 2025. See changelog.

See all results for this search

Track over 71,000 companies

Discover
Fast-growing Global startups

Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.

Pricing + Sign up

5

Funding Rounds

$390.0m

Money raised

PathAI is a Boston-based artificial intelligence company developing therapeutics and healthcare products.

6

Funding Rounds

$356.3m

Money raised

Insilico Medicine is a drug discovery, artificial intelligence company that looks to treat cancer and age related diseases

Location:

Key people:

10

Funding Rounds

$930.0m

Money raised

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.

8

Funding Rounds

$71.3m

Money raised

Notable Labs is a company providing personalized drug combination testing service for cancer patients.

4

Funding Rounds

$49.6m

Money raised

Inato matches the right sites to the right clinical research study, globally.

Location:

Key people:

4

Funding Rounds

$76.3m

Money raised

AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.

Key people:

9

Funding Rounds

$82.6m

Money raised

Biotherapeautics company founded in 2014 and based in Paris that uses proprietary methods in synthetic biology, protein and genome engineering to produce Eligobiotics, products which intervene with the microbiome as diagnostics, antimicrobials and modulators of host-microbiome interactions.

Location:

Key people:

6

Funding Rounds

$15.8m

Money raised

Massive Bio is a New York-based company founded by Selin Kurnaz, Dr. Arturo Loaiza-Bonilla and Cagatay M. Culcuoglu, offering precision oncology services to cancer patients, providers, and pharmaceutical companies.

2

Funding Rounds

$98.0m

Money raised

OrphAI Therapeutics is a biotechnology research company based in Guilford, Connecticut that develops precision therapeutics technology designed to treat cancer and rare diseases.

3

Funding Rounds

$54.1k

Money raised

ApexQubit is a biotechnology company that is harnessing a proprietary technology for discovery of new medicines to treat patients with undruggable diseases.

10

Funding Rounds

$36.3m

Money raised

Chronicled is a blockchain company founded by Ryan Orr, Samantha Radocchia, Maurizio Greco and David Aho.

8

Funding Rounds

$92.7m

Money raised

Develops medicines for patients suffering from Alzheimer's disease and other neurological disorders.

3

Funding Rounds

$31.2m

Money raised

Deep Lens is an Artificial Intelligence company matching patients with clinical trials.

Industries:

Key people:

5

Funding Rounds

$155.6m

Money raised

Athelas is a company developing blood testing device that utilizes deep learning and computer vision.

3

Funding Rounds

$34.0m

Money raised

Deep 6 AI is an artificial Intelligence company founded by Wout Brusselaers.

Key people:

5

Funding Rounds

$2.5m

Money raised

Ichor Therapeutics is a pre-clinical contract research on aging mechanisms company founded in 2013 by Kelsey Moody.

Key people:

7

Funding Rounds

$65.4m

Money raised

Mendel.ai is a life science company offering an artificial intelligence platform to aid clinical experts improve their clinical cancer research.

4

Funding Rounds

$7.1m

Money raised

Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.

Location:

Key people:

7

Funding Rounds

$443.5m

Money raised

Biofourmis is a global health IT start-up in Massachusetts that focuses on personalized care and therapies using digital therapeutics.

Key people:

2

Funding Rounds

$25.0m

Money raised

Reverie Labs is a drug dicovery company that uses machine learning founded by Jonah Kallenbach.

Location:

Key people:

3

Funding Rounds

$105.0m

Money raised

A biopharmaceutical company developing therapeutics for treating age-related diseases.

1

Funding Rounds

$12.0m

Money raised

An artificial intelligence company with a platform to be used the drug discovery process. It was founded in 2017 and is located in New York City.

Location:

Key people:

3

Funding Rounds

$26.5m

Money raised

PostEra is a biotechnology company that uses machine learning for medicinal chemistry services.

1

Funding Rounds

NetraMark is a Toronto-based machine learning software company founded by Joseph Geraci in 2015.

2

Funding Rounds

$20.2m

Money raised

A biotechnology company developing a drug-screening platform for the acceleration of drug discovery by combining custom laboratory assay and proprietary machine learning algorithms.

Location:

Key people:

1

Funding Rounds

$650.0k

Money raised

Anviro Therapeutics is a biotechnology company developing broad spectrum antiviral therapies.

4

Funding Rounds

$124.1m

Money raised

Healx is a biotechnology therapeutics company for rare diseases founded in 2014 by Tim Guilliams.

Key people:

7

Funding Rounds

$506.6m

Money raised

Medable's offers a healthcare application that provides patient-generated data for researchers, health startups, pharmaceuticals and universities.

2

Funding Rounds

$2.6m

Money raised

Precision therapeutics company developing epigenetic therapies that target arginine methylation in cancer.

Location:

Key people:

2

Funding Rounds

$8.1m

Money raised

SEngine Precision Medicine is a precision medicine company founded by Brady Bernard, Carla Grandori, Christopher Kemp, and VK Gadi.

Location:

Key people:

4

Funding Rounds

$226.0m

Money raised

Arrakis is developing RNA-targeted small molecule (rSM) therapies to millions of patients.

3

Funding Rounds

$31.0m

Money raised

Mekonos is a company that creates cell-engineering platforms

2

Funding Rounds

$42.0m

Money raised

Atomic AI is a biotechnology company specializing in the development of a platform for RNA drug discovery.

2

Funding Rounds

$8.0m

Money raised

ScienceIO is a Boston-based company developing an artificial intelligence-powered evidence exploration and synthesis platform.

Location:

Key people:

3

Funding Rounds

$76.0m

Money raised

Orexigen Therapeutics is a biopharmaceutical company developing treatments for obesity founded in 2002 by Eckard Weber.

Key people:

1

Funding Rounds

$2.2m

Money raised

A virtual assistant in Italy that focuses on improving people's quality of life and supporting the process of developing innovative and personalized drugs.

3

Funding Rounds

$18.4m

Money raised

A company using metabolic engineering and synthetic biology to produce biochemicals from renewable feedstocks.

Location:

Key people:

3

Funding Rounds

$5.7m

Money raised

Coral is a biotechnology company, founded in 2018, that creates large datasets which represent the diversity of human biology to improve development and deployment of drugs and make clinical trials more efficient through predicting patient responses to drugs.

Key people:

1

Funding Rounds

$2.5m

Money raised

Targazyme is a biotechnology company focused on improving survival and quality of life for cancer patients using stem cell transplantation, immunotherapy, regenerative medicine, and gene therapy.

1

Funding Rounds

$54.0m

Money raised

A biotechnology company discovering drugs that target the epitranscriptomics machinery that modifies RNA.

6

Funding Rounds

$5.1m

Money raised

A proteomics-based diagnostics company providing research services for the development of personalized medicine

3

Funding Rounds

$156.0m

Money raised

Trialspark is a company founded in 2013 by Benjamine Liu, kit dobyns and linhao zhang.

Key people:

6

Funding Rounds

$76.9m

Money raised

Aiforia is a Helsinki-based artificial intelligence company developing image analysis technology for diagnostics.

Location:

Key people:

2

Funding Rounds

$80.0m

Money raised

Datavant is a San Francisco-based company founded in 2017.

Location:

Key people:

1

Funding Rounds

Entos Pharmaceuticals develops nucleic acid-based therapies using its proprietary Fusogenix drug delivery system.

2

Funding Rounds

Immunobiochem is a biotechnology company that is committed to addressing unmet medical need in oncology via research and development of novel, targeted biological therapeutics.

5

Funding Rounds

$69.9m

Money raised

Unlearn is a San Francisco, California-company developing artificial intelligence tools and software for medical research.

Location:

Key people:

9

Funding Rounds

$15.9m

Money raised

NemaMetrix is a drug discovery company founded in 2011 by Matt Beaudet.

Location:

Key people:

4

Funding Rounds

$8.0m

Money raised

Phenomic AI is a Toronto-based company.

Location:

Key people:

4

Funding Rounds

$2.0m

Money raised

celldom is a single cell omics company founded in 2016 by Zach Forbes, Benjamin Yellen and Kris Wood.

5

Funding Rounds

$94.3m

Money raised

Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases.

3

Funding Rounds

$18.0m

Money raised

Ionpath is a Menlo Park, California-based medical diagnostic tool company.

3

Funding Rounds

$13.5m

Money raised

A company developing treatments for cancer and autoimmune diseases

1

Funding Rounds

$4.2m

Money raised

A company making voice recognition products capable of detecting cognitive decline and cognitive impairment based on samples of speech.

1

Funding Rounds

Clinilabs is a global, full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug development. With deep expertise in CNS, we are committed to the development of medicines that treat a range of psychiatric, neurological, and substance use disorders, as well as rare and ultra-rare CNS diseases.

Key people:

2

Funding Rounds

$135.3m

Money raised

Expansion Therapeutics is a RNA Targeted Small Molecules founded in 2016.

6

Funding Rounds

$195.8m

Money raised

AstronauTx is a London-based biotechnology research company developing treatments for neurogenerative diseases.

1

Funding Rounds

$2.8m

Money raised

Qynapse provides an FDA-Cleared neuroimaging software platform.

1

Funding Rounds

$1.2m

Money raised

ValiRx PLC. is a Cambridge, Massachusetts-based healthcare accelerator working to develop new medicines and technologies founded in 2000.

1

Funding Rounds

$2.0m

Money raised

A biotechnology company developing targeted cell-based immunotherapies for the treatment of cancer

2

Funding Rounds

$1.5m

Money raised

Microdermics is a skincare company founded in 2014 by Grant Campany, Boris Stoeber, Sahan Ranamukhaarachchi and Iman Mansoor.

1

Funding Rounds

$7.2m

Money raised

A company developing drugs that halt tumor growth and disrupt metastasis

3

Funding Rounds

$27.0k

Money raised

KPI Therapeutics is a company that focuses on developing potentially game changing autoimmune therapies.

Key people:

1

Funding Rounds

$21.0m

Money raised

BioMotiv is a company focused on advancng therapeutics development founded in 2012.

2

Funding Rounds

$21.3m

Money raised

Developer of ADCs to treat metastatic solid tumors.

Location:

Key people:

2

Funding Rounds

$4.4m

Money raised

GERO is a small Molecules founded in 2015 by Maxim Kholin.

Location:

Key people:

2

Funding Rounds

$6.6m

Money raised

Deep Intelligent Pharma is a drug researching company with focus in artificial intelligence.

1

Funding Rounds

Dalriada Therapeutics is a Mississauga-based research and development company offering a diagnostics and drug discovery platform.

1

Funding Rounds

$28.7m

Money raised

Lumicell is a cancer imaging device technology founded in 2009.

Sign up to access our full database

Enter your email and get access to 71,000 + technology companies you can partner with.

Join 29000+ founders, operators, and investors.